{
  "symbol": "ABBV",
  "year": 2023,
  "period": "Q1",
  "curated_text": "Symbol: ABBV. Year: 2023. Period: Q1. ReportType: Q10. Section: Competition and Market Position. This section discusses competitors, market dynamics, and regulatory landscape.  Competitors mentioned: the California Business and Professions Code, AndroGel, King Drug Co., Florence, Inc., Solvay Pharmaceuticals, Inc., Abbott, sham litigation, the State of, Oregon Circuit Court, Forest Laboratories, LLC, Bystolic Antitrust Litigation, MDL, National Prescription Opiate Litigation, the United States Tax Court, AbbVie Inc., Subsidiaries, the Internal Revenue Service, Shareholder and Securities Litigation, Holwill, Humira, Allergan plc Securities Litigation, Treppel Family Trust, the Food and Drug Administration\u2019s, Camargo, Allergan Inc., the U.S. Patent Office, Intellectual Property Litigation AbbVie Inc., Reddy\u2019s Laboratories, Ltd., Reddy\u2019s Laboratories, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., Alembic Global Holdings SA, Genentech, Inc., Venclexta, CODM, Venclexta United, Juvederm Collection United, Vraylar United States, Eye Care Ozurdex, Lumigan/Ganfort United States, 111 Total, Linzess/Constella United, ANALYSIS OF FINANCIAL CONDITION, the Condensed Consolidated Financial Statements, Supplementary Data, Research and Development Research, the European Commission, EC, the European Medicines Agency\u2019s, EMA, Rinvoq, the Committee for Medicinal Products for Human Use (, the U.S. Food and Drug Administration, FDA, TNF, HS, Vitiligo, INSPIRE, COMMAND, Phase 4 IMMpulse, PsO, Phase 3, Imbruvica \u2022, MCL, MZL, Imbruvica, Navitoclax \u2022, Venclexta \u2022, VenDex, Skinvive, Botox Cosmetic \u2022, BoNT, Neuroscience, Complete Response Letter, CRL, the New Drug Application, NDA, Percent, Botox Cosmetic, COVID-19, Juvederm Collection, Botox Therapeutic, Vraylar, Ubrelvy, SG&A, lower litigation reserve charges, Upfront, Syndesi Therapeutics SA, Consolidated Financial Statements, Non-Operating Expenses (Income, LIQUIDITY, Credit Risk AbbVie. Context excerpt: competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott acquired in February 2010 and now known as AbbVie Products LLC) with three generic companies violated federal antitrust law, and also alleging that 2011 patent litigation by Abbott with two generic companies regarding AndroGel was sham litigation and the settlements of those litigations violated federal antitrust law. Plaintiffs generally seek monetary damages and/or injunctive relief and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circu",
  "competition_summary": [
    {
      "competitor": "the California Business and Professions Code",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "AndroGel",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "King Drug Co.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Florence, Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Solvay Pharmaceuticals, Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Abbott",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "sham litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the State of",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Oregon Circuit Court",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Forest Laboratories",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "LLC",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Bystolic Antitrust Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "MDL",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "National Prescription Opiate Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the United States Tax Court",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "AbbVie Inc.",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Subsidiaries",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the Internal Revenue Service",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Shareholder and Securities Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Holwill",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Humira",
      "mentions": 13,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Allergan plc Securities Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Treppel Family Trust",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the Food and Drug Administration\u2019s",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Camargo",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Allergan Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the U.S. Patent Office",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Intellectual Property Litigation AbbVie Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Reddy\u2019s Laboratories, Ltd.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Reddy\u2019s Laboratories",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Alembic Pharmaceuticals Ltd.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Alembic Pharmaceuticals, Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Alembic Global Holdings SA",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Genentech, Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Venclexta",
      "mentions": 3,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "CODM",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Venclexta United",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Juvederm Collection United",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Vraylar United States",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Eye Care Ozurdex",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Lumigan/Ganfort United States",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "111 Total",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Linzess/Constella United",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "ANALYSIS OF FINANCIAL CONDITION",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the Condensed Consolidated Financial Statements",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Supplementary Data",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Research and Development Research",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the European Commission",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "EC",
      "mentions": 4,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the European Medicines Agency\u2019s",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "EMA",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Rinvoq",
      "mentions": 3,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the Committee for Medicinal Products for Human Use (",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the U.S. Food and Drug Administration",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "FDA",
      "mentions": 9,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "TNF",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "HS",
      "mentions": 3,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Vitiligo",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "INSPIRE",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "COMMAND",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Phase 4 IMMpulse",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "PsO",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Phase 3",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Imbruvica \u2022",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "MCL",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "MZL",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Imbruvica",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Navitoclax \u2022",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Venclexta \u2022",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "VenDex",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Skinvive",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Botox Cosmetic \u2022",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "BoNT",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Neuroscience",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Complete Response Letter",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "CRL",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "the New Drug Application",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "NDA",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Percent",
      "mentions": 6,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Botox Cosmetic",
      "mentions": 3,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "COVID-19",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Juvederm Collection",
      "mentions": 3,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Botox Therapeutic",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Vraylar",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Ubrelvy",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "SG&A",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "lower litigation reserve charges",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Upfront",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Syndesi Therapeutics SA",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Consolidated Financial Statements",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Non-Operating Expenses (Income",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "LIQUIDITY",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    },
    {
      "competitor": "Credit Risk AbbVie",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In August 2019, direct purchasers of AndroGel filed a lawsuit, King Drug Co. of Florence, Inc., et al. v. AbbVie Inc., et al., against AbbVie and others in the United States District Court for the Eastern District of Pennsylvania, alleging that 2006 patent litigation settlements and related agreements by Solvay Pharmaceuticals, Inc. (a company Abbott "
    }
  ]
}